Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
InChi: InChI=1S/C19H10N2O3/c22-18-13-5-3-4-10-11(19(23)24)8-9-12(16(10)13)17-20-14-6-1-2-7-15(14)21(17)18/h1-9H
COC1=CC2=NC(=NC(N)=C2C=C1OC)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1
PubMed PMID: 11082439
Emerging evidence suggests that it possesses efficacy in treating a number of viral infections as well
Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I)
SN-38 Size:Solid 2 mg InChi: InChI=1S/C19H10N2O3/c22-18-13-5-3-4-10-11(19(23)24)8-9-12(16(10)13)17-20-14-6-1-2-7-15(14)21(17)18/h1-9HSN 38 is the active metabolite of irinotecan (an analog of camptothecin a topoisomerase I inhibitor); it is 1000 times more active than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN 38 relative to irinotecan varies from 2 to 2000 fold. SN38 is metabolized via glucoronidation by UGT1A1. The variant of UGT1A1 in ~10% of Caucasians which leads to poor metabolization of irinotecan predicts irinotecan toxicity, as it cannot be
US$ 20.00
US$ 20.00
US$ 104.50
US$ 189.00
US$ 12.99
US$ 18.99